Lipid peroxidation dysregulation in ischemic stroke: Plasma 4-HNE as a potential biomarker?

Biochemical and Biophysical Research Communications

Volumn 425, Issue 4, 2012, Pages 842-847

  Lee, Wan Chi ^a,c   Wong, Hau Yang ^b,c   Chai, Yun Yong ^b   Shi, Chan Wei ^a   Amino, Naoya ^d   Kikuchi, Shizuki ^d   Huang, Shin Hai ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY   (Taiwan)

^c UNIVERSITY OF IOWA   (United States)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

4 HNE; ALDH2; Apoptosis; Autophagy; Biomarker; Ischemic stroke; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE BCL 2; BIOLOGICAL MARKER; GLUTATHIONE; GLUTATHIONE DISULFIDE; HOMOCYSTEINE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; BRAIN ISCHEMIA; BRAIN TISSUE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LIPID PEROXIDATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK FACTOR;

AGED; ALDEHYDE DEHYDROGENASE; ALDEHYDES; ANIMALS; BIOLOGICAL MARKERS; BRAIN; CELL SURVIVAL; HOMOCYSTEINE; HUMANS; LIPID PEROXIDATION; MALE; NEURONS; OXIDATIVE STRESS; PC12 CELLS; RATS; RATS, INBRED SHR; STROKE;

RATTUS;

EID: 84866003024     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.002     Document Type: Article

References (44)

1. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
2. Yepes M., Roussel B.D., Ali C., Vivien D. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci. 2009, 32:48-55.
3. Liang B.A., Lew R., Zivin J.A. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues. Arch. Neurol. 2008, 65:1429-1433.
4. Imre S.G., Fekete I., Farkas T. Increased proportion of docosahexanoic acid and high lipid peroxidation capacity in erythrocytes of stroke patients. Stroke 1994, 25:2416-2420.
5. Cherubini A., Polidori M.C., Bregnocchi M., Pezzuto S., Cecchetti R., Ingegni T., di Iorio A., Senin U., Mecocci P. Antioxidant profile and early outcome in stroke patients. Stroke 2000, 31:2295-2300.
6. Wang Q., Sun A.Y., Simonyi A., Miller D.K., Smith R.E., Luchtefeld R.G., Korthuis R.J., Sun G.Y. Oral administration of grape polyphenol extract ameliorates cerebral ischemia/reperfusion-induced neuronal damage and behavioral deficits in gerbils: comparison of pre- and post-ischemic administration. J. Nutr. Biochem. 2009, 20:369-377.
7. Ritz M.F., Ratajczak P., Curin Y., Cam E., Mendelowitsch A., Pinet F., Andriantsitohaina R. Chronic treatment with red wine polyphenol compounds mediates neuroprotection in a rat model of ischemic cerebral stroke. J. Nutr. 2008, 138:519-525.
8. Sakata Y., Zhuang H., Kwansa H., Koehler R.C., Dore S. Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp. Neurol. 2010, 224:325-329.
9. Mauthe M., Jacob A., Freiberger S., Hentschel K., Stierhof Y.D., Codogno P., Proikas-Cezanne T. Resveratrol-mediated autophagy requires WIPI-1-regulated LC3 lipidation in the absence of induced phagophore formation. Autophagy 2011, 7:1448-1461.
10. Belayev L., Liu Y., Zhao W., Busto R., Ginsberg M.D. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 2001, 32:553-560.
11. Huang J., Agus D.B., Winfree C.J., Kiss S., Mack W.J., McTaggart R.A., Choudhri T.F., Kim L.J., Mocco J., Pinsky D.J., Fox W.D., Israel R.J., Boyd T.A., Golde D.W., Connolly E.S. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc. Natl. Acad. Sci. USA 2001, 98:11720-11724.
12. Cherubini A., Ruggiero C., Polidori M.C., Mecocci P. Potential markers of oxidative stress in stroke. Free Radical Biol. Med. 2005, 39:841-852.
13. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radical Biol. Med. 2009, 47:469-484.
14. Sharpe P.C., Mulholland C., Trinick T. Ascorbate and malondialdehyde in stroke patients. Ir. J. Med. Sci. 1994, 163:488-491.
15. Chang C.Y., Lai Y.C., Cheng T.J., Lau M.T., Hu M.L. Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan. Free Radical Res. 1998, 28:15-24.
16. Okun E., Arumugam T.V., Tang S.C., Gleichmann M., Albeck M., Sredni B., Mattson M.P. The organotellurium compound ammonium trichloro(dioxoethylene-0,0') tellurate enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice. J. Neurochem. 2007, 102:1232-1241.
17. Nagotani S., Hayashi T., Sato K., Zhang W., Deguchi K., Nagano I., Shoji M., Abe K. Reduction of cerebral infarction in stroke-prone spontaneously hypertensive rats by statins associated with amelioration of oxidative stress. Stroke 2005, 36:670-672.
18. Belayev L., Alonso O.F., Busto R., Zhao W., Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 1996, 27:1616-1622. (discussion 23).
19. Hsin I.L., Ou C.C., Wu T.C., Jan M.S., Wu M.F., Chiu L.Y., Lue K.H., Ko J.L. GMI, an immunomodulatory protein from Ganoderma microsporum, induces autophagy in non-small cell lung cancer cells. Autophagy 2011, 7:873-882.
20. Chen S.Y., Chiu L.Y., Maa M.C., Wang J.S., Chien C.L., Lin W.W. ZVAD-induced autophagic cell death requires c-Src-dependent ERK and JNK activation and reactive oxygen species generation. Autophagy 2011, 7:217-228.
21. Bhutia S.K., Das S.K., Azab B., Dash R., Su Z.Z., Lee S.G., Dent P., Curiel D.T., Sarkar D., Fisher P.B. Autophagy switches to apoptosis in prostate cancer cells infected with melanoma differentiation associated gene-7/interleukin-24 (Mda-7/IL-24). Autophagy 2011, 7:1076-1077.
22. Germain M., Slack R.S. MCL-1 regulates the balance between autophagy and apoptosis. Autophagy 2011, 7:549-551.
23. Lim J., Kim H.W., Youdim M.B., Rhyu I.J., Choe K.M., Oh Y.J. Binding preference of p62 towards LC3-ll during dopaminergic neurotoxin-induced impairment of autophagic flux. Autophagy 2011, 7:51-60.
24. Liu Y.L., Yang P.M., Shun C.T., Wu M.S., Weng J.R., Chen C.C. Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy 2010, 6:1057-1065.
25. Lu H.H., Kao S.Y., Liu T.Y., Liu S.T., Huang W.P., Chang K.W., Lin S.C. Areca nut extract induced oxidative stress and upregulated hypoxia inducing factor leading to autophagy in oral cancer cells. Autophagy 2010, 6:725-737.
26. Petrovski G., Ayna G., Majai G., Hodrea J., Benko S., Madi A., Fesus L. Phagocytosis of cells dying through autophagy induces inflammasome activation and IL-1beta release in human macrophages. Autophagy 2010, 7:321-330.
27. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis, JAMA 288 (2002) 2015-22.
28. Lovell M.A., Ehmann W.D., Mattson M.P., Markesbery W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 1997, 18:457-461.
29. Zarkovic K. 4-hydroxynonenal and neurodegenerative diseases. Mol. Aspects Med. 2003, 24:293-303.
30. McKracken E., Graham D.I., Nilsen M., Stewart J., Nicoll J.A., Horsburgh K. 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia. Brain Pathol. 2001, 11:414-421.
31. Farooqui A.A., Horrocks L.A. Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly. Neuroscientist 2006, 12:245-260.
32. Lu X.R., Ong W.Y., Halliwell B., Horrocks L.A., Farooqui A.A. Differential effects of calcium-dependent and calcium-independent phospholipase A(2) inhibitors on kainate-induced neuronal injury in rat hippocampal slices. Free Radical Biol. Med. 2001, 30:1263-1273.
33. Zhang F., Yin W., Chen J. Apoptosis in cerebral ischemia: executional and regulatory signaling mechanisms. Neurol. Res. 2004, 26:835-845.
34. Tian F., Deguchi K., Yamashita T., Ohta Y., Morimoto N., Shang J., Zhang X., Liu N., Ikeda Y., Matsuura T., Abe K. In vivo imaging of autophagy in a mouse stroke model. Autophagy 2011, 6:1107-1114.
35. Shen H.M., Codogno P. Autophagic cell death: loch ness monster or endangered species?. Autophagy 2011, 7:457-465.
36. Carloni S., Girelli S., Scopa C., Buonocore G., Longini M., Balduini W. Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia. Autophagy 2010, 6:366-377.
37. R. Sheng, L.S. Zhang, R. Han, X.Q. Liu, B. Gao, Z.H. Qin, Autophagy activation is associated with neuroprotection in a rat model of focal cerebral ischemic preconditioning, Autophagy 6 (2010).
38. Rodriguez-Muela N., Boya P. Axonal damage, autophagy and neuronal survival. Autophagy 2011, 8:286-288.
39. Grishchuk Y., Ginet V., Truttmann A.C., Clarke P.G., Puyal J. Beclin 1-independent autophagy contributes to apoptosis in cortical neurons. Autophagy 2011, 7:1115-1131.
40. Bartlett B.J., Isakson P., Lewerenz J., Sanchez H., Kotzebue R.W., Cumming R.C., Harris G.L., Nezis I.P., Schubert D.R., Simonsen A., Finley K.D. P62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. Autophagy 2011, 7:572-583.
41. Zhang X., Li L., Chen S., Yang D., Wang Y., Wang Z., Le W. Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy 2011, 7:412-425.
42. West R.J., Sweeney S.T. Oxidative stress and autophagy: mediators of synapse growth?. Autophagy 2011, 8:284-285.
43. Zheng L., Terman A., Hallbeck M., Dehvari N., Cowburn R.F., Benedikz E., Kagedal K., Cedazo-Minguez A., Marcusson J. Macroautophagy-generated increase of lysosomal amyloid beta-protein mediates oxidant-induced apoptosis of cultured neuroblastoma cells. Autophagy 2011, 7:1528-1545.
44. Tanne D., Haim M., Goldbourt U., Boyko V., Doolman R., Adler Y., Brunner D., Behar S., Sela B.A. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke 2003, 34:632-636.